Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 5
2007 6
2008 5
2009 6
2010 8
2011 6
2012 14
2013 8
2014 15
2015 9
2016 10
2017 5
2018 8
2019 9
2020 9
2021 11
2022 10
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sang yong kim (221 results)?
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.
Park C, Lee HS, Kang KW, Lee WS, Do YR, Kwak JY, Shin HJ, Kim SY, Yi JH, Lim SN, Lee JO, Yang DH, Jang H, Choi B, Lim J, Sun CH, Byun JM, Yoon SS, Koh Y. Park C, et al. Among authors: kim sy. Nat Commun. 2024 Mar 30;15(1):2776. doi: 10.1038/s41467-024-47198-4. Nat Commun. 2024. PMID: 38555311 Free PMC article. Clinical Trial.
Bilateral Sudden Hearing Loss in Iron Deficiency Anemia.
Choi JW, Kim SY, Kim CH. Choi JW, et al. Among authors: kim sy. Cureus. 2024 Feb 20;16(2):e54505. doi: 10.7759/cureus.54505. eCollection 2024 Feb. Cureus. 2024. PMID: 38516496 Free PMC article.
Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).
Cho H, Kim K, Yoon SE, Jung SH, Lee JJ, Moon JH, Cho HJ, Lee HS, Kang KW, Kim SY, Eom HS, Mun YC, Park YH, Yoon SS, Do YR, Lee WS, Min CK, Yoon DH. Cho H, et al. Among authors: kim sy. Hemasphere. 2024 Jan 26;8(1):e33. doi: 10.1002/hem3.33. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434530 Free PMC article. No abstract available.
Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
Bae SJ, Kim HJ, Kim HA, Ryu JM, Park S, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Park E, Kim SY, Lee MH, Kim LS, Lee A, Noh WC, Gwark S, Kim S, Jeong J. Bae SJ, et al. Among authors: kim sy. Int J Surg. 2024 Feb 1;110(2):934-942. doi: 10.1097/JS9.0000000000000907. Int J Surg. 2024. PMID: 38000057 Free PMC article.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Baek SY, et al. Among authors: kim sy. J Clin Oncol. 2023 Nov 1;41(31):4864-4871. doi: 10.1200/JCO.23.00557. Epub 2023 Aug 22. J Clin Oncol. 2023. PMID: 37607321 Clinical Trial.
141 results